Meeting
2016 Genitourinary Cancers Symposium
Carboplatin-based sequential chemotherapy for advanced bladder cancer patient with impaired renal function.
Authors
Takahiro Yoneyama
Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Takahiro Yoneyama , Jotaro Mikami , Naoki Fujita , Tendo Sato , Yuta Kojima , Hiromichi Iwamura , Atsushi Imai , Shingo Hatakeyama , Yasuhiro Hashimoto , Takuya Koie , Chikara Ohyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 401)
DOI
10.1200/jco.2016.34.2_suppl.401
Abstract #
401
Poster Bd #
G14
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Carboplatin-based sequential chemotherapy for aged patients with advanced bladder cancer.
First Author: Takahiro Yoneyama
Poster
2013 Genitourinary Cancers Symposium
Sequential chemotherapy with gemcitabine plus carboplatin followed by additional docetaxel for older patients with advanced bladder cancer.
First Author: Takahiro Yoneyama
Poster
2021 ASCO Annual Meeting
A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib (2ND-STEP, JCOG1802).
First Author: Makoto Endo
Poster
2016 Genitourinary Cancers Symposium
Sequential chemotherapy with gemcitabine+carboplatin followed by gemcitabine+carboplatin+docetaxel for advanced upper-tract urothelial cancer.
First Author: Takahiro Yoneyama